Stabilization of Oxidative Stress 1 Year after Kidney Transplantation: Effect of Calcineurin Immunosuppressives

REFERENCES

• Pita-Fernandez S, Pertega-Diaz S, Valdes-Canedo F, . Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: Study protocol. BMC Cardiovasc Disord. 2011;11(1):2.
   PubMedGoogle Scholar
• Demirci S, Sekeroğlu MR, Noyan T, . The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis. Cell Biochem Funct. 2011;29(3):249–254.
   PubMedGoogle Scholar
• Hambali Z, Ahmad Z, Arab S, Khazaai H. Oxidative stress and its association with cardiovascular disease in chronic renal failure patients. Indian J Nephrol. 2011;21(1):21–25.
   PubMedGoogle Scholar
• Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007;6(8):662–680.
   PubMed Web of Science ®Google Scholar
• Nafar M, Sahraei Z, Salamzadeh J, et al. Oxidative stress in kidney transplantation: Causes, consequences, and potential treatment. Iran J Kidney Dis. 2011;5(6):357–372.
   Google Scholar
• Chrzanowska M, Kamińska J, Głyda M, Duda G, Makowska E. Antioxidant capacity in renal transplant patients. Pharmazie. 2010;65(5):363–366.
   PubMedGoogle Scholar
• Vural A, Yilmaz MI, Caglar K, . Assessment of oxidative stress in the early posttransplant period: Comparison of cyclosporine A and tacrolimus-based regimens. Am J Nephrol. 2005;25(3):250–255.
   PubMed Web of Science ®Google Scholar
• Cofan F, Cofan M, Campos B, Guerra R, Campistol JM, Oppenheimer F. Effect of calcineurin inhibitors on low-density lipoprotein oxidation. Transplant Proc. 2005;37(9):3791–3793.
   PubMedGoogle Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, . Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304–1313.
   PubMed Web of Science ®Google Scholar
• Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–310.
   PubMedGoogle Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192–205.
   PubMed Web of Science ®Google Scholar
• Ewing JF, Janero DR. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal Biochem. 1995;232(2):243–248.
   PubMedGoogle Scholar
• Tappel AL. Glutathione peroxidase and hydroperoxides. Methods Enzymol.. 1995;52:506–513.
   Google Scholar
• Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;195(1):133–140.
   PubMed Web of Science ®Google Scholar
• Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004; 364(9447):1814–1827.
   PubMed Web of Science ®Google Scholar
• Antolini F, Valente F, Ricciardi D, Baroni M, Fagugli RM. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Clin Chim Acta. 2005;358(1–2):87–94.
   PubMedGoogle Scholar
• Aveles PR, Criminácio CR, Gonçalves S, . Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation. Nephron Clin Pract. 2010;116(4):c294–299.
   PubMedGoogle Scholar
• Mitra S, Goyal T, Mehta JL. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 2011;25(5):419–429.
   PubMed Web of Science ®Google Scholar
• Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci. 2011;342(2):135–142.
   PubMed Web of Science ®Google Scholar
• Holvoet P, Cleemput JV, Collen D, Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 2000;20(3):698–702.
   PubMedGoogle Scholar
• Kimak E, Hałabiś M, Baranowicz-Gąszczyk I, Solski J, Książek A. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients. J Zhejiang Univ Sci B. 2011;12(5):365–371.
   PubMedGoogle Scholar
• Emre H, Keles M, Yildirim S, . Comparison of the oxidant-antioxidant parameters and sialic acid levels in renal transplant patients and peritoneal dialysis patients. Transplant Proc. 2011;43(3):809–812.
   PubMedGoogle Scholar
• De Vega L, Pérez Fernández R, Martin Mateo MC, . Study of the activity of glutathione-peroxidase, glutathione-transferase, and glutathione-reductase in renal transplants. Transplant Proc. 2003;35(4):1346–1350.
   PubMedGoogle Scholar
• Moreno JM, Ruiz MC, Ruiz N, . Modulation factors of oxidative status in stable renal transplantation. Transplant Proc. 2005;37(3):1428–1430.
   PubMedGoogle Scholar
• McGrath LT, Treacy R, McClean E, Brown JH. Oxidative stress in cyclosporin and azathioprine treated renal transplant patients. Clin Chim Acta. 1997;264(1):1–12.
   PubMedGoogle Scholar
• Sharma A, Jain S, Gupta R, . Ultrastructural alterations in endothelial mitochondria are associated with enhanced nitrotyrosine accumulation and progressive reduction of VEGF expression in sequential protocol renal allograft biopsies with calcineurin inhibitor toxicity. Transpl Int. 2010;23(4):407–416.
   PubMedGoogle Scholar
• Varghese Z, Fernando RL, Turakhia G, . Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. Kidney Int Suppl. 1999;71:S137–140.
   Google Scholar
• Ponticelli C, Cucchiari D, Graziani G. Hypertension in kidney transplant recipients. Transpl Int. 2011;24(6):523–533.
   PubMed Web of Science ®Google Scholar
• Cattaneo D, Remuzzi G. Lipid oxidative stress and the anti-inflammatory properties of statins and ACE inhibitors. J Ren Nutr. 2005;15(1):71–76.
   PubMedGoogle Scholar
• Campese VM, Park J. HMG-CoA reductase inhibitors and the kidney. Kidney Int. 2007;71(12):1215–1222.
   PubMedGoogle Scholar
• Calò LA, Davis PA, Giacon B, . Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: Effect of ramipril. J Cardiovasc Pharmacol. 2002; 40(4):625–631.
   PubMed Web of Science ®Google Scholar
• Haririan A, Metireddy M, Cangro C, . Association of serum uric acid with graft survival after kidney transplantation: A time-varying analysis. Am J Transplant. 2011;11(9):1943–1950.
   PubMedGoogle Scholar
• Goicoechea M, de Vinuesa SG, Verdalles U, . Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010;5(8):1388–1393.
   PubMed Web of Science ®Google Scholar
• Toussaint ND, Elder GJ, Kerr PG. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol. 2009; 4(1):221–233.
   PubMed Web of Science ®Google Scholar